0001752724-24-132302.txt : 20240613
0001752724-24-132302.hdr.sgml : 20240613
20240613142306
ACCESSION NUMBER: 0001752724-24-132302
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 3
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
EFFECTIVENESS DATE: 20240613
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUTUAL FUND SERIES TRUST
CENTRAL INDEX KEY: 0001355064
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-21872
FILM NUMBER: 241040836
BUSINESS ADDRESS:
STREET 1: C/O GEMINI FUND SERVICES LLC
STREET 2: 4221 NORTH 203RD STREET, SUITE 100
CITY: ELKHORN
STATE: NE
ZIP: 68022-3474
BUSINESS PHONE: 631 549 1859
MAIL ADDRESS:
STREET 1: C/O GEMINI FUND SERVICES LLC
STREET 2: 4221 NORTH 203RD STREET, SUITE 100
CITY: ELKHORN
STATE: NE
ZIP: 68022-3474
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST FUNDS
DATE OF NAME CHANGE: 20060303
0001355064
S000048680
AlphaCentric Income Opportunities Fund
C000153405
AlphaCentric Income Opportunities Fund Class A
IOFAX
C000153406
AlphaCentric Income Opportunities Fund Class C
IOFCX
C000153407
AlphaCentric Income Opportunities Fund Class I
IOFIX
0001355064
S000055006
AlphaCentric Premium Opportunity Fund
C000173003
AlphaCentric Premium Opportunity Fund Class A
HMXAX
C000173004
AlphaCentric Premium Opportunity Fund Class C
HMXCX
C000173005
AlphaCentric Premium Opportunity Fund Class I
HMXIX
0001355064
S000057714
AlphaCentric Robotics and Automation Fund
C000186116
AlphaCentric Robotics and Automation Fund Class A
GNXAX
C000186117
AlphaCentric Robotics and Automation Fund Class C
GNXCX
C000186118
AlphaCentric Robotics and Automation Fund Class I
GNXIX
0001355064
S000066020
AlphaCentric Symmetry Strategy Fund
C000213450
AlphaCentric Symmetry Strategy Fund Class I
SYMIX
C000213451
AlphaCentric Symmetry Strategy Fund Class A
SYMAX
C000213452
AlphaCentric Symmetry Strategy Fund Class C
SYMCX
0001355064
S000067055
AlphaCentric LifeSci Healthcare Fund
C000215729
AlphaCentric LifeSci Healthcare Fund Class C
LYFCX
C000215730
AlphaCentric LifeSci Healthcare Fund Class I
LYFIX
C000215731
AlphaCentric LifeSci Healthcare Fund Class A
LYFAX
0001355064
S000071674
AlphaCentric Strategic Income Fund
C000227116
AlphaCentric Strategic Income Fund Class I
SIIIX
C000227117
AlphaCentric Strategic Income Fund Class A
SIIAX
C000227118
AlphaCentric Strategic Income Fund Class C
SIICX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001355064
XXXXXXXX
811-21872
N-1A
S000057714
C000186116
C000186118
C000186117
S000067055
true
S000071674
true
S000055006
C000173003
C000173005
C000173004
S000066020
true
S000048680
C000153405
C000153406
C000153407
Mutual Fund Series Trust
811-21872
0001355064
5493002ZGLQMLR4QMA96
4221 NORTH 203RD STREET, SUITE 100
Elkhorn
68022-3474
US-NE
US
631-549-1859
Ultimus Fund Solutions, LLC
225 Pictoria Drive, Suite 450
Cincinnati
45246
631-470-2600
Records related to its function as administrator, accounting agent and transfer agent
N
N
N-1A
35
Y
Stephen P. Lachenauer
N/A
N
Tiberiu Weisz
N/A
N
Jerry Szilagyi
N/A
Y
Tobias Caldwell
N/A
N
Frederick J. Schmidt
N/A
36 N. New York Avenue
Huntington
11743
XXXXXX
N
N
N
N
N
N
Northern Lights Distributors LLC
8-65857
000126159
N/A
Y
N
Cohen & Company
925
N/A
N
Y
N
N
N
N
AlphaCentric Robotics and Automation Fund
S000057714
549300E21ZG78LC2JI72
N
3
0
0
N/A
N
N
Y
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
N/A
6631117.45166666
219614.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
Contego Capital Group, Inc.
801-113844
000128518
N/A
N
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
74994.47000000
74994.47000000
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
1602906.32000000
1602906.32000000
N
28990162.52319672
Uncommitted
100000000.00000000
N
N
N
AlphaCentric LifeSci Healthcare Fund
S000067055
549300XV4TMPQ6UX8179
N
3
0
0
N/A
N
N
N
N
N/A
N/A
N/A
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
LifeSci Fund Management LLC
801-117201
000305001
N/A
N
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
SVB Leerink LLC
8-48535
000039011
549300AAH7U76CEUBI94
28209.53000000
Jonestrading Institutional Services LLC
8-26089
000006888
2138008JJ5PA8H5UIL69
750.00000000
William Blair & Company, L.L.C
8-2698
000001252
549300J0P7XYE8BMZ775
9827.10000000
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
38611.78000000
Jefferies Group
8-15074
000002347
58PU97L1C0WSRCWADL48
94328.05000000
RBC Capital Markets, LLC
8-45411
000031194
549300LCO2FLSSVFFR64
18261.33000000
R.J. O'Brien Securities, LLC
8-67587
000143624
549300Y3W4512F4J2D08
35962.17000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
450.54000000
Oppenheimer & Co. Inc
8-4077
000000249
254900VH02JQR2L8XD64
46815.59000000
273216.09000000
Jefferies Group
8-15074
000002347
58PU97L1C0WSRCWADL48
965749.72000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
1890000.00000000
William Blair & Company, L.L.C
8-2698
000001252
549300J0P7XYE8BMZ775
72500.00000000
Goldman Sachs & Co LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
126000.00000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
115500.00000000
SVB Leerink LLC
8-48535
000039011
549300AAH7U76CEUBI94
3234750.00000000
6404499.71999999
N
99329190.57633882
Uncommitted
100000000.00000000
N
N
N
N
AlphaCentric Strategic Income Fund
S000071674
549300YDYHXBQRIQH163
N
3
0
0
N/A
N
N
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
Goshen Rock Capital, LLC
801-120776
000313546
N/A
N
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
Jonestrading Institutional Services LLC
8-26089
000006888
2138008JJ5PA8H5UIL69
283.50000000
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
862.35000000
Cantor Fitzgerald & Co.
8-201
000000134
5493004J7H4GCPG6OB62
12639.47000000
Odeon Capital Group LLC
8-68033
000148493
549300S158163H2DN048
12.54000000
13797.86000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
1255003.85055080
Bmo Capital Markets Corp.
8-34344
000016686
RUC0QBLBRPRCU4W1NE59
3347516.47605208
Performance Trust Capital Partners, LLC
8-47035
000036155
549300F8NR5Q23JRIY74
3206454.65635343
Stephens Inc.
8-1927
000003496
213800LH6T9XDYZCA534
1526643.97970714
Goldman Sachs & Co LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
4659050.00000000
Browstone Investment Group LLC
8-50460
000043884
549300EBC8OHVQMGF416
1146681.32005960
Odeon Capital Group LLC
8-68033
000148493
549300S158163H2DN048
2798832.80776745
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
1500106.20099600
Seaport Global Securities LLC
8-53535
000116270
54930028D6D0G5RZJ888
4221712.77094045
Wells Fargo Securities, LLC
8-65876
000126292
VYVVCKR63DVZZN70PB21
1360806.15014000
25022808.21256697
N
55813009.70710378
Uncommitted
100000000.00000000
N
N
N
AlphaCentric Premium Opportunity Fund
S000055006
54930050MG8D4Y1NZE85
N
3
0
0
N/A
N
N
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4 (17 CFR 270.18f-4)
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
Interactive Brokers
8-47257
000036418
50OBSE5T5521O6SMZR28
53452.84000000
53452.84000000
STONEX FINANCIAL INC
8-51269
000045993
549300LNKU6K5TJCRG93
69996898.64374999
U.S. Bancorp Investments, Inc.
8-35359
000017868
H85Z6XZP8B10ES0M2G89
14529694.69999999
84526593.34375000
N
81564632.27620220
Uncommitted
100000000.00000000
N
N
N
N
AlphaCentric Symmetry Strategy Fund
S000066020
549300KS6XKZRXD32T67
N
3
0
0
N/A
Y
N
N
N/A
N/A
N/A
Rule 18f-4 (17 CFR 270.18f-4)
Rule 32a-4 (17 CFR 270.32a-4)
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
Mount Lucas Management LP
801-28254
000108255
549300KGSSFB18TBWK88
N
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
RBC Capital Markets, LLC
8-45411
000031194
549300LCO2FLSSVFFR64
1719.69000000
SG Americas Securities, LLC
8-66125
000128351
549300F35UE0BOM1WJ55
13364.24000000
15083.93000000
SG Americas Securities, LLC
8-66125
000128351
549300F35UE0BOM1WJ55
71024685.22785100
71024685.22785100
N
43537468.49568305
Uncommitted
100000000.00000000
N
N
N
AlphaCentric Income Opportunity Fund
S000048680
549300G5GDKQ1HGLKQ58
N
3
0
0
N/A
N
N
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Y
Y
Y
N
AlphaCentric Advisors LLC
801-79616
000170679
N/A
N
Garrison Point Capital, LLC
801-77191
000165590
254900DD7OOGDOE3TP64
N
N
Ultimus Fund Solutions, LLC
84-05829
N/A
N
N
N
ICE Data Services
5493000NQ9LYLDBCTL34
N/A
N
Pricing Direct
549300WIC0TOJ7N7GD54
N/A
N
N
U.S. Bank National Association
6BYL5QZYBDK8S7L73M02
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
Ultimus Fund Solutions, LLC
84-05829
Filing Number
N
N
N
Ultimus Fund Solutions, LLC
84-06083
Filing Number
N
N
N
0.00
Piper Sandler & Co.
8-15204
000000665
549300GRQCWQ3XGH0H10
57602218.06652957
Brean Capital, LLC
8-40742
000023723
254900ZZA1UBVDCNQ378
48200857.40589024
Mesirow Financial, Inc.
8-28816
000002764
549300BIV46SUHPOFE54
8397767.19757499
Bmo Capital Markets Corp.
8-34344
000016686
RUC0QBLBRPRCU4W1NE59
27216873.66471250
CitiGroup Inc.
8-8177
000007059
6SHGI4ZSSLCXXQSBB395
380850747.94853956
BTIG, LLC
8-65473
000122225
549300GTG9PL6WO3EC51
27680143.21664229
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
21891241.40625000
Browstone Investment Group LLC
8-50460
000043884
549300EBC8OHVQMGF416
183192501.79609323
Odeon Capital Group LLC
8-68033
000148493
549300S158163H2DN048
49510519.18984872
SG Americas Securities, LLC
8-66125
000128351
549300F35UE0BOM1WJ55
9091040.75110444
813633910.64318562
N
454006468.55401659
Uncommitted
100000000.00000000
N
N
N
true
true
LEGAL PROCEEDINGS
2
Income_Legal_Proceeding.txt
INCOME LEGAL PROCEEDING
AlphaCentric Income Opportunities Fund
LEGAL PROCEEDINGS
On July 30, 2020, an investor in the AlphaCentric Income
Opportunities Fund (the "Fund") filed a putative class action in
Florida state court, naming AlphaCentric Advisors LLC, Mutual Fund
Series Trust, and others as defendants. Plaintiff alleges that the Fund
misrepresented that it held no more than 15% of its assets in illiquid
securities, among other things, and asserts violations of Sections 11,
12(a)(2) and 15 of the Securities Act of 1933. On October 14,
2020, the same Plaintiff filed a nearly identical putative class action in
New York State Court against the same defendants. That complaint
was amended on February 26, 2021, which added two additional
defendants, including sub-advisor Garrison Point LLC. On February
22, 2021, defendants moved to dismiss the Florida action for lack of
personal jurisdiction. On May 20, 2020, defendants moved to
dismiss the New York action for failure to allege any material
misrepresentations or omissions, among other things. We believe
these lawsuits are meritless and intend to contest them vigorously.
INTERNAL CONTROL RPT
3
Internal_Control_Letter.txt
ALPHACENTRIC FUNDS IC LETTER 3.31.2024
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Shareholders of AlphaCentric Income Opportunities
Fund, AlphaCentric Premium Opportunity Fund, AlphaCentric
Robotics and Automation Fund, AlphaCentric Symmetry
Strategy Fund, AlphaCentric LifeSci Healthcare Fund, and
AlphaCentric Strategic Income Fund and Board of Trustees of
Mutual Fund Series Trust
In planning and performing our audit of the financial
statements of AlphaCentric Income Opportunities Fund,
AlphaCentric Premium Opportunity Fund, AlphaCentric
Robotics and Automation Fund, AlphaCentric LifeSci
Healthcare Fund, AlphaCentric Strategic Income Fund and the
consolidated financial statements of AlphaCentric Symmetry
Strategy Fund (the "Funds"), each a series of Mutual Fund
Series Trust, as of and for the year ended March 31, 2024, in
accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), we
considered the Funds internal control over financial
reporting, including controls over safeguarding securities, as a
basis for designing our auditing procedures for the purpose of
expressing our opinion on the financial statements and to
comply with the requirements of Form N-CEN, but not for the
purpose of expressing an opinion on the effectiveness of the
Funds internal control over financial reporting. Accordingly,
we express no such opinion.
The management of the Funds is responsible for establishing
and maintaining effective internal control over financial
reporting. In fulfilling this responsibility, estimates and
judgments by management are required to assess the
expected benefits and related costs of controls. A funds
internal control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial
statements for external purposes in accordance with
generally accepted accounting principles (GAAP). A funds
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
fund; (2) provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial
statements in accordance with GAAP, and that receipts and
expenditures of the fund are being made only in accordance
with authorizations of management and trustees of the fund;
and (3) provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use or
disposition of a funds assets that could have a material effect
on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial reporting exists
when the design or operation of a control does not allow
management or employees, in the normal course of
performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a
deficiency, or combination of deficiencies, in internal control
over financial reporting, such that there is a reasonable
possibility that a material misstatement of the Funds annual
or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Funds internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies
in internal control that might be material weaknesses under
standards established by the PCAOB. However, we noted a
deficiency in the Funds internal control over financial
reporting and its operation, including controls over
safeguarding securities, that we consider to be a material
weakness as defined above as of March 31, 2024.
Due to system limitations, the accretion of discount on an
investment in a deeply discounted security had to be tracked
and recorded manually in an offline schedule. Controls did
not allow for the capture of all the trading activity in the
offline schedule for this security, resulting in a material
adjustment to the recorded accretion. We believe this
represents a material weakness in internal control over
financial reporting.
This report is intended solely for the information and use of
management and the Board of Trustees of the Funds and the
Securities and Exchange Commission and is not intended to
be and should not be used by anyone other than these
specified parties.
/s/ COHEN & COMPANY, LTD.
Philadelphia, Pennsylvania
May 30, 2024